Ahmed Shokeir

Prof. Dr. Ahmed Shokeir


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Journal of Urology
Verified
Journal Article
Closed access
AEAhmed R. El-Nahas
Ahmed R. El-Nahas
ASAhmed Shokeir
Ahmed Shokeir
AEAhmed M. El-Assmy
Ahmed M. El-Assmy
TMTarek Mohsen
Tarek Mohsen
ASAhmed M. Shoma
Ahmed M. Shoma
HEHamdy A. El-Kappany
Hamdy A. El-Kappany
We identified risk factors predicting severe bleeding due to percutaneous nephrolithotomy. Computerized data on 2,909 patients who underwent a total of 3,878 percutaneous nephrolithotomy procedures between January 1995 and December 2005 were retrospectively reviewed. Data on patients who experienced severe bleeding requiring angiographic renal embolization were compared with those on other patients using univariate and multivariate analyses. We tested the characteristics of patients, kidneys and stones together with details of the operative procedure and surgeon experience. Severe bleeding complicated a total of 39 procedures (1%) in 25 males and 14 females with a mean age of 50.7 +/- 12.6 years. Associated morbidity included shock in 6 patients and perirenal hematoma in 4. Renal angiography revealed pseudoaneurysm in 20 patients, arteriovenous fistula in 9, the 2 lesions in 8 and arterial laceration in 2. Bleeding could be controlled with superselective embolization in 36 patients (92.3%). Followup was available on 33 patients (mean 21 +/- 15 months). Renal function was stable in all patients except 3 who had a post-embolization increase in serum creatinine, of whom all had a solitary kidney and none required renal replacement therapy. Significant risk factors for severe bleeding were upper caliceal puncture, solitary kidney, staghorn stone, multiple punctures and inexperienced surgeon. Percutaneous nephrolithotomy should be performed by an experienced endourologist in patients at risk for severe bleeding, such as those with a solitary kidney or staghorn stones.

1 September 2010 in European Urology
Verified
Journal Article
Closed access
AAAbdulla Al-Ansari
Abdulla Al-Ansari
NYNagy Younes
Nagy Younes
VSVenkataramana Pai Sampige
Venkataramana Pai Sampige
KAKhalid Al-Rumaihi
Khalid Al-Rumaihi
AGArdalan Ghafouri
Ardalan Ghafouri
ASAhmed Shokeir
Ahmed Shokeir

1 May 1997 in Urology
Verified
Journal Article
Closed access
ASAhmed Shokeir
Ahmed Shokeir
MEMohamed El-Azab
Mohamed El-Azab
TMTarek Mohsen
Tarek Mohsen
TETarek El-Diasty
Tarek El-Diasty

1 March 2007 in Urology
Verified
Journal Article
Closed access
AAAhmed M. Al-Kandari
Ahmed M. Al-Kandari
HSHani Shabaan
Hani Shabaan
HIHamdi M. Ibrahim
Hamdi M. Ibrahim
YEYehya H. Elshebiny
Yehya H. Elshebiny
ASAhmed Shokeir
Ahmed Shokeir

1 February 2005 in Journal of Urology
Verified
Journal Article
Closed access
KAKhaled M. Al-Kohlany
Khaled M. Al-Kohlany
ASAhmed Shokeir
Ahmed Shokeir
AMAhmed Mosbah
Ahmed Mosbah
TMTarek Mohsen
Tarek Mohsen
ASAhmed M. Shoma
Ahmed M. Shoma
HEHamdy A. El-Kappany
Hamdy A. El-Kappany
We studied the role of open surgery versus percutaneous nephrolithotomy (PCNL) in the treatment of complete staghorn stones in a prospective randomized manner. A total of 79 patients with 88 complete staghorn stones, defined as filling the entire collecting system or at least 80% of it, were prospectively randomized for PCNL (43) or open surgery (45). Intraoperative and postoperative morbidity, operative time, hospital stay, and stone clearance at discharge home and followup were compared for both methods. Patients with significant residuals in both groups were subjected to extracorporeal shock wave lithotripsy (Dornier Medical Systems, Inc., Marietta, Georgia) on an outpatient basis. Followup was completed for all cases with a mean duration +/- SD of 4.9 +/- 2.5 months (range 3 to 14). Renal function was evaluated by Tc-mercaptoacetyltriglycine renogram before and after treatment in both groups. Intraoperative complications in terms of bleeding requiring blood transfusion, and pleural, vascular or ureteral injuries were recorded in 7 patients (16.3%) in the PCNL and 17 (37.8%) in the open surgery groups, a difference of significant value (p <0.05). Major postoperative complications including massive hematuria requiring blood transfusion, septicemia, urinary leakage and wound infection were observed in 8 patients (18.6%) in the PCNL group and in 14 (31.1%) in the open surgery group, a difference of no significant value. PCNL was associated with shorter operative time (127 +/- 30 vs 204 +/- 31 minutes, p <0.001), shorter hospital stay (6.4 +/- 4.2 vs 10 +/- 4.2 days, p <0.001) and earlier return to work (2.5 +/- 0.8 vs 4.1 +/- 1 weeks, p <0.001). On the other hand both treatment groups were comparable in regard to stone-free rates at discharge home (49% vs 66%) and at followup (74% vs 82%). At followup renal function improved or remained stable in 91% and 86.7% in the PCNL and open surgery groups, respectively. PCNL is a valuable treatment option for complete staghorn stones with a stone-free rate approaching that of open surgery. Moreover, it has the advantages of lower morbidity, shorter operative time, shorter hospital stay and earlier return to work.

19 December 2003 in BJU International
Verified
Journal Article
Closed access
PDF file
ASAhmed Shokeir
Ahmed Shokeir